Senate bill would save money and allow generics to reach market more quickly, according to CBO report
September 20, 2018Business Services, Medical Communications, Sales and Marketing CBO, Senate, US, biosimilars, generics, law, politics
The Congressional Budget Office (CBO) has said in a report that a bipartisan bill awaiting a vote in the senate …
FDA greenlights Teva’s migraine drug Ajovy in two dosage options
September 20, 2018Sales and Marketing FDA, Teva, US, ajovy, migraine, pharma
Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a …
MSD to launch Keytruda at half US list price in China
September 20, 2018Business Services, Sales and Marketing BMS, China, MSD, global, keytruda, markets, pricing
US pharma giant MSD will offer cutting edge cancer treatment Keytruda to Chinese patients at half the price at what …
Almirall’s Ilumetri scores EU approval in chronic plaque psoriasis
September 19, 2018Research and Development, Sales and Marketing Almirall, EADV 2018, Ilumetri, pharma, psoriasis
Hot on the heels of the European Academy of Dermatology and Venereology Congress (EADV) 2018 where psoriasis took centre stage, …
NICE rejects CAR-T therapy Kymriah for DLBCL in adults
September 19, 2018Research and Development CAR T, CAR-T, Kymriah, NICE, Novartis, leukaemia
The National Institute for health and Care Excellence (NICE) has rejected Novartis’ CAR-T therapy Kymriah for use in adults with …
Novartis to relocate Arnhem operations to Amsterdam, 400 jobs affected
September 19, 2018Manufacturing and Production, Research and Development Netherlands, Novartis, amsterdam, pahrma, pharma
Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, …
AstraZeneca to increase presence in China
September 19, 2018Research and Development AstraZeneca, China, alibaba, governemnt, tencent
The Anglo-Swedish multinational AstraZeneca is moving towards becoming a major healthcare provider in China as part of an effort to …
FDA expand REMS education program in effort against opioid crisis
September 19, 2018Research and Development FDA, IR, opioid crisis, opioids, rems
The US Food and Drug Administration is set to introduce a requirement that all healthcare providers be offered educational training …
Cancer Research UK announces new £14m research hub in London
September 18, 2018Manufacturing and Production, Research and Development CRUK, Cancer, pharma
Cancer Research UK has announced a £14 million investment to build a new hub in London for cancer research and …
Rates of vaccination decline in England, study shows
September 18, 2018Manufacturing and Production England, NHS, health, public health, vaccines, vacinnation
The number of people who are receiving the 12 routine childhood vaccinations has declined in proportion to the eligible population …
US Senate pass bipartisan bill to tackle opioid crisis
September 18, 2018Manufacturing and Production Senate, US, epidemic, opioid, opioid crisis, politics
The US Senate have passed a bipartisan bill aimed at combatting the opioid crisis. The bill, which was passed with …
US House of Representatives blocks drug pricing advert bill
September 18, 2018Manufacturing and Production Big Pharma, Drug pricing, HHS, Trump, Twitter, adverts
A ruling which would force pharmaceutical companies to disclose the price of their drugs in television advertisements has been set …
400 jobs to go as Novo Nordisk overhauls R&D operations
September 18, 2018Manufacturing and Production, Sales and Marketing Novo Nordisk, pharma
Novo Nordisk has revealed its intention to restructure its research & development operations “to accelerate the expansion and diversification of …
Sanofi’s Dupixent improves symptoms for adolescent atopic dermatitis patients
September 17, 2018Research and Development, Sales and Marketing Dupixent, EADV 2018, Sanofi, atopic dermatitis, pharma
Sanofi’s Dupixent (dupilumab) has made a strong showing as a monotherapy at Phase 3 in the treatment of moderate-to-severe atopic …
FDA approves AstraZeneca’s Lumoxiti for hairy cell leukaemia (HCL)
September 17, 2018Sales and Marketing AstraZeneca, HCL, Lumoxiti, leukaemia, rare diseases
AstraZeneca’s Lumoxiti has been approved for use for the treatment of relapsed or refractory hairy cell leukemia (HCL)in adults who …
Allergan acquires neurotoxin specialist Bonti in $195m deal
September 17, 2018Sales and Marketing Allergan, Bonti, Botox, Neurotoxin, acquisition, deal
The Dublin-headquartered multinational Allergan have agreed to acquire the clinical stage biotech Bonti in a deal worth more than $195 …
Teva shares soar after migraine treatment Ajovy approval
September 17, 2018Sales and Marketing FDA, Teva, US, ajovy, approval, israel
Shares in the Israeli pharma firm Teva soared on Sunday after the announcement that the US Food and Drug Administration …
NICE recommends Novartis combo as first-ever BRAF-targeted therapy for advanced post-surgery melanoma
September 17, 2018Sales and Marketing Cancer, NICE, Novartis, Tafinlar, mekinist, melanoma, pharma
NICE has taken the decision to recommend the first ever first BRAF-targeted therapy for use on the NHS in England …
Ex-GSK R&D head joins OxStem as CSO
September 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, OxStem, University of Oxford
OxStem, a regenerative drug discovery unit spun out from the University of Oxford, has brought on board ex-GlaxoSmithKline R&D exec …
Aileron Therapeutics name Dr Manuel Aivado as new President and CEO
September 14, 2018Aileron, CEO, Massachusetts, Watertown, appointments
The Watertown Massachusetts-based stapled peptide therapeutics specialist Aileron Therapeutics has appointed former SVP, Chief Medical & Scientific Officer Dr Manuel …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
